Medpace Holdings, Inc.
▲ 1 upgrades / ▼ 0 downgrades / 6 reiterations from 5 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Oct 23, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Oct 23, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Oct 23, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Oct 7, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Oct 7, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Sep 30, 2026 | UBS | upgrade | Sell → Neutral | — | 54% |
| Jul 24, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 24, 2026 | BMO Capital | maintain | Market Perform → Market Perform | — | 53% |
| Jul 24, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Jul 24, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Jul 24, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 24, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Jul 13, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 8, 2026 | Baird | downgrade | Outperform → Neutral | — | 55% |
| Jul 7, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Apr 24, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Apr 24, 2026 | BMO Capital | maintain | Market Perform → Market Perform | — | 53% |
| Apr 24, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Apr 24, 2026 | Baird | maintain | Outperform → Outperform | — | 55% |
| Mar 6, 2026 | Barclays | upgrade | Underweight → Equal-Weight | — | 53% |
| Mar 3, 2026 | RBC Capital | initiate | — → Outperform | — | 55% |
| Feb 18, 2026 | TD Cowen | upgrade | Sell → Hold | $419 | 54% |
| Feb 13, 2026 | Jefferies | upgrade | Hold → Buy | $560 | 52% |
| Feb 11, 2026 | Barclays | maintain | Underweight → Underweight | $500 | 53% |
| Feb 11, 2026 | Truist Securities | maintain | Hold → Hold | $539 | 54% |
| Feb 11, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | $485 | 51% |
| Dec 15, 2025 | Barclays | maintain | Underweight → Underweight | $525 | 53% |
| Nov 13, 2025 | BMO Capital | initiate | — → Market Perform | $600 | 53% |
| Oct 27, 2025 | Truist Securities | maintain | Hold → Hold | $555 | 54% |
| Oct 24, 2025 | TD Cowen | maintain | Sell → Sell | $462 | 54% |
| Oct 24, 2025 | Barclays | maintain | Underweight → Underweight | $485 | 53% |
| Oct 24, 2025 | Mizuho | maintain | Outperform → Outperform | $655 | 52% |
| Oct 17, 2025 | Mizuho | maintain | Outperform → Outperform | $575 | 52% |
| Oct 2, 2025 | Barclays | downgrade | Equal-Weight → Underweight | $425 | 53% |
| Sep 9, 2025 | Jefferies | maintain | Hold → Hold | $450 | 52% |
| Sep 3, 2025 | Rothschild & Co | downgrade | Buy → Neutral | $474 | 56% |
| Jul 29, 2025 | UBS | downgrade | Neutral → Sell | $305 | 54% |
| Jul 25, 2025 | Mizuho | maintain | Outperform → Outperform | $510 | 52% |
| Jul 23, 2025 | Truist Securities | maintain | Hold → Hold | $436 | 54% |
| Jul 23, 2025 | Deutsche Bank | maintain | Hold → Hold | $430 | 57% |
| Jul 23, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $450 | 53% |
| Jul 23, 2025 | Baird | maintain | Neutral → Neutral | $490 | 55% |
| Jul 23, 2025 | TD Cowen | downgrade | Hold → Sell | $366 | 54% |
| Jun 24, 2025 | Barclays | initiate | — → Equal-Weight | $300 | 53% |
| Apr 23, 2025 | Truist Securities | maintain | Hold → Hold | $300 | 54% |
| Apr 23, 2025 | Baird | maintain | Neutral → Neutral | $313 | 55% |
| Apr 22, 2025 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Apr 14, 2025 | TD Cowen | downgrade | Buy → Hold | $328 | 54% |
| Apr 10, 2025 | Truist Securities | maintain | Hold → Hold | $333 | 54% |
No cross-platform signals in the last 90 days